LMWH contra LMWH: superior, equivalent or non-inferior?
نویسندگان
چکیده
منابع مشابه
Treating thrombosis in neonates with LMWH.
Low molecular weight heparin (LMWH) might be an alternative to established treatment for deep vein thrombosis in neonates, London researchers report.
متن کاملLow-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Thromboembolic complications are a common and costly medical problem, associated with significant morbidity and mortality, especially in postoperative patients. There have been reports of death due to thromboembolic complications even after short procedures, e.g. arthroscopy. Low-molecular-weight heparins (LMWHs) (e.g., certoparin, dalteparin, enoxaparin, nadroparin, reviparin, tinzaparin) have...
متن کاملLimitation of vWf meta-analysis in LMWH comparison.
Differences in clinical efficacy between unfractionated heparin (UFH) and low molecular weight heparin (LMWH) but also between several LMWH preparations are a hot topic in research due to differences in study results: enoxaparin proved superiority over UFH (1,2), whereas dalteparin and nadroparin showed only equivalence (3,4). As there is a lack of trials directly comparing LMWHs, some investig...
متن کاملCan LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?
AIM OF THE STUDY Lung cancer is the most common malignancy, accounting for one-third of all deaths from cancer. Some studies have shown that low molecular weight heparin (LMWH) significantly prolongs the survival of patients with non-small cell lung cancer (NSCLC). The aim of this study was to determine the effects of treating inoperable stage III NSCLC with LMWH in addition to concurrent chemo...
متن کاملACP Journal Club: review: factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement.
Commentary VTE is an important complication of major orthopedic surgery. Advances in surgical technique, early ambulation, and early hospital discharge coupled with safer and more effective pharmacologic agents have reduced the risk for symptomatic VTE (DVT or PE). Rates of symptomatic VTE of 15% to 30% after TKR or THR before 1980 have been reduced to 1% to 2% in some recent studies (1, 2) thr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thrombosis and Haemostasis
سال: 2003
ISSN: 1538-7933
DOI: 10.1046/j.1538-7836.2003.00164.x